This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_LIPORALPHARYNX_EXALLC for full statistics.
Carcinoma in situ of lip, oral cavity and pharynx
CD2_INSITU_LIPORALPHARYNX
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D00.0
Hospital discharge: ICD-9
2300
Cause of death: ICD-10
D00.0
Cause of death: ICD-9
2300
2 out of 7 registries used, show all original rules.
69
Check minimum number of events None
69
Include endpoints None
69
Remove individuals based on genotype QC
67
CD2_INSITU_LIPORALPHARYNX
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D00
Name in latin
Carcinoma in situ labii (oris)
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of lip, oral cavity and pharynx
based on the number of shared cases.
Broader endpoints:
- Carcinoma in situ of lip, oral cavity and pharynx (controls excluding all cancers)
- Carcinoma in situ of oral cavity, oesophagus and stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach (controls excluding all cancers)
- In situ neoplasms (controls excluding all cancers)
- In situ neoplasms
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 67 | 23 | 44 |
| Unadjusted prevalence (%) | 0.02 | 0.01 | 0.02 |
| Mean age at first event (years) | 64.21 | 60.51 | 66.14 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_LIPORALPHARYNX – Carcinoma in situ of lip, oral cavity and pharynx
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Carcinoma in situ of lip, oral cavity and pharynx
↥Endpoint not on priority list, no data to show.